Creative Biolabs Showcases Antibody Arrays for Protein Profiling, AKT Signaling and Autophagy Research
Oct 21, 2026
Complementary array formats support broad biomarker exploration and focused studies of signaling and cellular regulation.
Shirley, New York, United States, October 21, 2026 /MarketersMEDIA/ -- Creative Biolabs is highlighting three antibody array products that offer complementary approaches to protein research: a broad human biomarker proteomics array, an AKT pathway phosphorylation array, and a human autophagy array. The products provide options for researchers investigating protein abundance, signaling changes, and autophagy-related responses within a defined experimental setting.
Protein research often requires both a broad view of biological changes and a closer examination of specific molecular processes. A large screening panel can help identify candidate proteins for further study, while focused arrays can support investigation of selected pathways. Creative Biolabs' portfolio addresses these different research needs through glass slide and membrane formats.
Broad Profiling for Biomarker Exploration
The company's Human Biomarker Proteomics Antibody Array features 1,000 targets on a glass slide platform. Listed for quantitative detection of human proteins, the array accommodates sample types including cell culture supernatants, cell lysates, plasma, serum, tissue lysates, and other body fluids.
This broad coverage gives researchers an option for exploring protein profiles before selecting candidates for more focused analysis. Experimental design, sample preparation, and subsequent confirmation remain important when interpreting differences between study groups or treatment conditions.
Focused Analysis of AKT Pathway Phosphorylation
For researchers examining signaling responses, the AKT Pathway Phosphorylation Antibody Array provides a membrane-based panel of 18 targets. The product is listed for human and mouse reactivity and uses a semi-quantitative assay format.
Its panel includes phosphorylated forms of Akt, AMPKα, mTOR, PRAS40, and PTEN, among other signaling proteins. Measuring selected phosphorylation events can add information beyond protein abundance alone, helping researchers investigate how experimental conditions affect components of the AKT-related signaling network.
The array uses chemiluminescent imaging following sample incubation and antibody-based detection, offering a focused format for comparing selected signaling readouts across experimental conditions.
Connecting Signaling Studies with Autophagy Research
The Human Autophagy Antibody Array complements this pathway-focused approach with a membrane-based, semi-quantitative panel covering 20 autophagy-related targets in human samples.
AKT-related signaling and autophagy intersect through regulatory networks involving cellular growth, nutrient sensing, and stress responses. Examining these areas within the same research program may help investigators develop hypotheses about relationships between signaling changes and autophagy-related protein profiles. Measurements of protein levels, however, require complementary functional experiments to establish changes in autophagic flux.
The three products can therefore be considered at different stages of a research project, from broad protein exploration to targeted pathway analysis. They are separate research tools, and their use should be guided by the biological question, species compatibility, sample characteristics, and the information each assay measures.
Researchers can review individual product specifications and contact Creative Biolabs to discuss suitability for their experimental requirements. All three arrays are intended for research use only and are not intended for clinical use.
About Creative Biolabs
Creative Biolabs provides antibody products and research services supporting life science investigations. Its portfolio includes primary and secondary antibodies, antibody pairs, and antibody arrays for applications in protein detection, biomarker research, and cellular signaling studies.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.antibody-creativebiolabs.com/
Release ID: 89206812
If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.
More News
Republicans Cut Taxes to Win the Midterms. It May Not Work Out.
Among the stakes in next month’s election is the long-running question of whether tax cuts can shape how people vote.
Fearing Mass A.I. Layoffs, Some in Congress Eye Ways to Aid Workers
A bill to bolster the nation’s unemployment insurance program reflects the concern — and the risks — in Washington.
A.I. and New Rules for Accounting Are an Opportunity for Start-Ups
Pennylane, a French company, has gained market share in its home country by helping accountants work with clients. It’s aiming to expand internationally.
Volvo Shares Plunge as China Ambitions Fade for Western Carmakers
The Swedish automaker plans to cut another 2,500 jobs, joining competitors in offering a gloomy view of the world’s biggest car market.
What is PHP and why did it spark a global cyber-security scramble?
AI uncovered long-hidden programming flaws, triggering a rare global cyber-security response.
Island inflation rate rises to 3%, figures show
The rising cost of food and alcohol drives an increase in the inflation rate, figures show.
Earnings limit of up to £140K for first-time buyers loan scheme
The Your First Home scheme will offer government-backed loans for those buying new-builds in England.
A Tech Rotation Roils the Markets, Again
Investors are bracing for a one-two punch: rising oil prices and concerns about the soaring costs of the artificial intelligence buildout.
A Simple Way to Benefit From Rising Rates: Buy Money Market Funds
While higher interest rates are a complication for stocks and bonds, they are an unequivocal boon if you just want to park some cash and make a little money, our columnist says.
Trump’s Plan to Import More Ground Beef Is Falling Short
About a fifth of the 300,000 metric tons of lean beef trimmings have come through customs, six weeks through a program designed to lower prices.
Melanoma Vaccine Ushers in New Hope for Cancer Patients
Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
What is the Budget and what could be in it?
Chancellor John Healey will set out his plans for UK taxes on 28 October.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.